Board Meeting1 Aug 2026, 04:00 pm
Emmessar Biotech Board Meeting on Aug 7 to Approve Q1 FY27 Results
AI Summary
Emmessar Biotech & Nutrition Ltd has announced that its Board of Directors will convene on August 7, 2026, in Mumbai. The primary agenda item for this meeting is to consider and approve the unaudited financial results for the quarter ended June 30, 2026. Additionally, the company has informed that the trading window, which was closed as per SEBI (Prohibition of Insider Trading) Regulations, 2015, will remain closed until August 9, 2026.
Key Highlights
- Board meeting scheduled for August 7, 2026.
- To consider and approve unaudited financial results for Q1 FY27.
- Trading window closure extended until August 9, 2026.
- Disclosure made as per SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.
Price Impact
More from EMMESSA